Atorvastatin ameliorates diabetic nephropathy through inhibiting oxidative stress and ferroptosis signaling.

This publication has 57 references indexed in Scilit:

• Statins, Mortality, and Major Adverse Cardiovascular Events Among US Veterans With Chronic Kidney Disease
  JAMA Network Open, 2023
• Sulforaphane alleviates high fat diet-induced insulin resistance via AMPK/Nrf2/GPx4 axis
  Biomedicine & Pharmacotherapy, 2022
• Association of Statin Therapy Initiation With Diabetes Progression
  JAMA Internal Medicine, 2021
• Atorvastatin treatment ameliorates cardiac function and remodeling induced by isoproterenol attack through mitigation of ferroptosis
  Biochemical and Biophysical Research Communications, 2021
• Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older
  JAMA, 2020
• Targeting oxidative stress and anti-oxidant defence in diabetic kidney disease
  Journal Of Nephrology, 2020
• Cellular Iron Metabolism and Regulation
  2019
• Statin users have an elevated risk of dysglycemia and new‐onset‐diabetes
  Diabetes/Metabolism Research and Reviews, 2019
• The effect of statins on renal outcomes in patients with diabetic kidney disease: A systematic review and meta‐analysis
  Diabetes/Metabolism Research and Reviews, 2017
• HPLC-based monitoring of products formed from hydroethidine-based fluorogenic probes — The ultimate approach for intra- and extracellular superoxide detection
  Biochimica et Biophysica Acta (BBA) - General Subjects, 2014